Antiagregg™ is a tool for health professionals taking care of patients suffering from acute coronary syndrome. When the treatment of acute coronary syndrome —most of the times in a scenario of urgency, regardless of method of reperfusion that we will use begins, we must decide for an antiplatelet P2Y12 inhibitor.
To do this we analyze multiple variables, such as the type of acute coronary syndrome, availability of a cath lab, coronary anatomy, clinical profile, and risk classification of the patient, the result of clinical studies, guides recommendation of experts, etc.
Antiagregg™ is an app that includes a decision algorithm based on all these variables, to guide and select the most appropriate antiplatelet therapy in each patient, intuitive and fast. Its design is based on the results of randomized studies, expert recommendations, and the pharmacological profile of the most used antiplatelets.
Features:
- Easy, fast and intuitive interfase.
- Reliable results.
- Regular updates, based on latest studies and experts recommendations.